These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31406349)
1. Gut microbiome alteration in MORDOR I: a community-randomized trial of mass azithromycin distribution. Doan T; Hinterwirth A; Worden L; Arzika AM; Maliki R; Abdou A; Kane S; Zhong L; Cummings ME; Sakar S; Chen C; Cook C; Lebas E; Chow ED; Nachamkin I; Porco TC; Keenan JD; Lietman TM Nat Med; 2019 Sep; 25(9):1370-1376. PubMed ID: 31406349 [TBL] [Abstract][Full Text] [Related]
2. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution. Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084 [TBL] [Abstract][Full Text] [Related]
3. Rapid Reduction of Hinterwirth A; Sié A; Coulibaly B; Ouermi L; Dah C; Tapsoba C; Zhong L; Chen C; Lietman TM; Keenan JD; Doan T; Oldenburg CE Am J Trop Med Hyg; 2020 Sep; 103(3):1266-1269. PubMed ID: 32524948 [No Abstract] [Full Text] [Related]
4. Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger. Arzika AM; Maliki R; Goodhew EB; Rogier E; Priest JW; Lebas E; O'Brien KS; Le V; Oldenburg CE; Doan T; Porco TC; Keenan JD; Lietman TM; Martin DL; Arnold BF; Nat Commun; 2022 Feb; 13(1):976. PubMed ID: 35190534 [TBL] [Abstract][Full Text] [Related]
5. Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial. Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL Am J Trop Med Hyg; 2020 Sep; 103(3):1319-1328. PubMed ID: 32342837 [TBL] [Abstract][Full Text] [Related]
6. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania. Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633 [TBL] [Abstract][Full Text] [Related]
7. Gut Microbial Diversity in Antibiotic-Naive Children After Systemic Antibiotic Exposure: A Randomized Controlled Trial. Doan T; Arzika AM; Ray KJ; Cotter SY; Kim J; Maliki R; Zhong L; Zhou Z; Porco TC; Vanderschelden B; Keenan JD; Lietman TM Clin Infect Dis; 2017 May; 64(9):1147-1153. PubMed ID: 28402408 [TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial. Hart JD; Kalua K; Keenan JD; Lietman TM; Bailey RL Am J Trop Med Hyg; 2020 Sep; 103(3):1283-1290. PubMed ID: 32342840 [TBL] [Abstract][Full Text] [Related]
9. Gut Microbiome Diversity and Antimicrobial Resistance After a Single Dose of Oral Azithromycin in Children: A Randomized Placebo-Controlled Trial. Doan T; Liu Z; Sié A; Dah C; Bountogo M; Ouattara M; Coulibaly B; Kiemde D; Zonou G; Nebie E; Brogdon J; Lebas E; Hinterwirth A; Zhong L; Chen C; Zhou Z; Porco T; Arnold BF; Oldenburg CE; Lietman TM Am J Trop Med Hyg; 2024 Feb; 110(2):291-294. PubMed ID: 38227963 [TBL] [Abstract][Full Text] [Related]
10. Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial. Pickering H; Hart JD; Burr S; Stabler R; Maleta K; Kalua K; Bailey RL; Holland MJ Gut Pathog; 2022 Jan; 14(1):5. PubMed ID: 34991704 [TBL] [Abstract][Full Text] [Related]